Creo Medical Group CREO.L · GBp

Its shares trade on LSE under the ticker CREO.L. It has been listed since 9 December 2016. In the fiscal year to 31 December 2025, it reported revenue of £6.0m and net income of £5.3m. At that date it held total assets of £59.1m and shareholders' equity of £50.0m.

Creo Medical Group Plc operates as a medical device company that focuses on surgical endoscopy. The company is headquartered in Chepstow, Monmouthshire/Sir Fynwy. The company went IPO on 2016-12-09. The firm focuses on the field of surgical endoscopy. The firm focuses on the development and commercialization of minimally invasive surgical devices, initially in the area of gastrointestinal (GI) surgery and lung cancer. The firm has developed CROMA, which is an electrosurgical platform that can deliver microwave and bipolar radiofrequency through a single accessory port. The firm's surgical system CROMA combines bipolar radiofrequency for localized cutting and microwave energy for controlled coagulation, which provides physicians with simplified and controlled surgical solutions. The firm's pipeline portfolio of instruments is targeted at three therapeutic endoscopic specialties: lower GI; lung/bronchoscopy and upper GI.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Kevin CroftonNon-Executive Independent Chairman of the Board£64,750
• Mr. Craig GullifordChief Executive Officer, Executive Director, since 2012£377,174
• Mr. Richard ReesChief Financial Officer, Executive Director, since 2016£264,633
• Prof. Christopher HancockChief Technology Officer, Executive Director£260,411
• Mr. David WoodsChief Commercial Officer, Executive Director, since 2020£312,916
• Mr. Brent BoucherIndependent Non-Executive Director£27,634
• Ms. Ivonne CantuIndependent Non-Executive Director£56,000

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.